Nymox, KlinLab Sign Marketing, Distribution Deal

Nymox Pharmaceutical announced that it has entered into a marketing and distribution agreement with KlinLab, a Czech Republic clinical laboratory company, for the marketing and sales of Nymox's AlzheimAlert product. Nymox's AlzheimAlert provides physicians with a valuable tool for the diagnosis of Alzheimer's disease by measuring levels of a biomarker for Alzheimer's disease in patient urine samples.

MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqL3QWdCbmduXBG)